STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 165-170

  Li, Jie ^a   Cui, Geng ^a   Sun, Lu ^a   Wang, Shu Juan ^a   Li, Ya Li ^a   Meng, Yuan Guang ^a   Guan, Zheng ^a   Fan, Wen Sheng ^a   Li, Li An ^a   Yang, Yi Zhuo ^a   You, Yan Qin ^a   Fu, Xiao Yu ^a   Yan, Zhi Feng ^a   Huang, Ke ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Acetylation; ARHI; DNMT1; Promoter methylation; STAT3

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE 1; STAT3 PROTEIN;

ACETYLATION; ADULT; ARHI GENE; ARTICLE; CANCER CELL; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ACETYLATION; ADULT; AZACITIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; RHO GTP-BINDING PROTEINS; STAT3 TRANSCRIPTION FACTOR;

EID: 84878171024     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2414     Document Type: Article

References (23)

1. Yu Y, Xu F, Peng H, et al: NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 96: 214-219, 1999. (Pubitemid 29036079)
2. Peng H, Xu F, Pershad R, et al: ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int J Cancer 86: 690-694, 2000. (Pubitemid 30249881)
3. Luo RZ, Fang X, Marquez R, et al: ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene 22: 2897-2909, 2003. (Pubitemid 36648916)
4. Zhao X, Li J, Zhuo J and Cai L: Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma. Biochem Biophys Res Commun 403: 417-421, 2010.
5. Zou CF, Jia L, Jin H, et al: Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer 11: 22, 2011.
6. Yang H, Lu X, Qian J, et al: Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells. Mol Med Rep 3: 581-587, 2010.
7. Kobayashi H, Kajiwara H, Kanayama S, et al: Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review). Oncol Rep 22: 233-240, 2009.
8. Luo RZ, Peng H, Xu F, et al: Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim Biophys Acta 1519: 216-222, 2001. (Pubitemid 32545431)
9. Feng W, Marquez RT, Lu Z, et al: Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 112: 1489-1502, 2008. (Pubitemid 351441161)
10. Yuan Z, Guan Y, Chatterjee D and Chin YE: Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307: 269-273, 2005. (Pubitemid 40116244)
11. Wang R, Cherukuri P and Luo J: Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem 280: 11528-11534, 2005. (Pubitemid 40418464)
12. Kimura K, Yamada T, Matsumoto M, et al: Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation. Diabetes 61: 61-73, 2012.
13. Morgan RJ, Alvarez RD, Armstrong DK, et al: Epithelial ovarian cancer. J Natl Compr Cancer Netw 9: 82-113, 2011.
14. Higashiura Y, Kajihara H, Shigetomi H and Kobayashi H: Identification of multiple pathways involved in the malignant transformation of endometriosis (Review). Oncol Lett 4: 3-9, 2012.
15. Lee H, Zhang P, Herrmann A, et al: Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci USA 109: 7765-7769, 2012.
16. Yuan J, Luo RZ, Fujii S, et al: Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 63: 4174-4180, 2003. (Pubitemid 36917943)
17. Sharda DR, Yu S, Ray M, et al: Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase. J Immunol 187: 2181-2192, 2011.
18. Badgwell DB, Lu Z, Le K, et al: The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Oncogene 31: 68-79, 2012.
19. Bao JJ, Le XF, Wang RY, et al: Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res 62: 7264-7272, 2002.
20. Lu Z, Luo RZ, Peng H, et al: Transcriptional and post-transcriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res 12: 2404-2413, 2006.
21. Qidwai MT, Jamal F, Singh D and Sharma RK: Factors modifying transcriptional regulation of signaling genes have putative role in tumor development and progression in humans. Med Hypotheses 79: 805-812, 2012.
22. Stark GR, Wang Y and Lu T: Lysine methylation of promoter-bound transcription factors and relevance to cancer. Cell Res 21: 375-380, 2011.
23. Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T and Wasik MA: STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA 102: 6948-6953, 2005. (Pubitemid 40675422)